Xuehua Sun

1.2k citations
49 papers · 877 indexed · h-index 17
Topics
Hepatitis B Virus Studies (20 papers)Liver Disease Diagnosis and Treatment (15 papers)Hepatitis C virus research (15 papers)
Journals
The LancetSHILAP Revista de lepidopterologíaScientific Reports

In The Last Decade

Xuehua Sun

47 papers receiving 872 citations

Peers

Xuehua Sun
Comparison fields: 5 of 91
  • Molecular Biology 338
  • Epidemiology 245
  • Immunology 222
  • Hepatology 186
  • Oncology 126
Replace Steffen Frese with:
Steffen Frese Switzerland
S Satoh Japan
Fujun Li China
Hai Feng China
Ruichuang Yang China
Jingde Wu China
Shuling Huang China
Shun Zhou China
Lijing Wang China
Sohji Nishina Japan
Xuehua Sun relative to Steffen Frese Switzerland Steffen Frese's profile →
Citations per field
00.5×9.9×
Steffen Frese · 1×
Citations per year

Countries citing papers authored by Xuehua Sun

Since Specialization
Citations

This map shows the geographic impact of Xuehua Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuehua Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuehua Sun more than expected).

Fields of papers citing papers by Xuehua Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuehua Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuehua Sun. The network helps show where Xuehua Sun may publish in the future.

Co-authorship network of co-authors of Xuehua Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xuehua Sun. A scholar is included among the top collaborators of Xuehua Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuehua Sun. Xuehua Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 18
3 1
4 3
5 16
6
Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma
15
7 8
8 26
9 24
10 5
11 27
12 33
13 5
14 3
15 5
16 8
17 1
18 40
19 8
20
Clinical Study on Chronic Hepatitis C Treated by "Liver-Clearing Granule
2

About Xuehua Sun

Xuehua Sun is a scholar working on Hepatology, Pharmacology and Epidemiology, having authored 49 papers that have together received 877 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (20 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hepatitis C virus research (15 papers). The work is most often cited by research in Hepatology (186 citations), Immunology (222 citations) and Pharmacology (89 citations). Xuehua Sun has collaborated with scholars based in China, Hong Kong and South Korea. Frequent co-authors include Yueqiu Gao, Xiaoni Kong, Man Li, Chang Yu, Zhuo Yu, Xiaojun Zhu, Bingrui Wang, Zhenhua Zhou, Jie Zhao and Hailong Wu. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026